ASN95 -- Selected abstracts: Mortality, Survival

Sun. Nov. 5 1995

9:30 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Dialysis adequacy: Estimates and results

Program number 231 Board# S231 at 10:45 A.M.
* Predictive value of adequacy and nutritional indices on mortality and morbidity on CAPD and HD. A longitudinal study. R. Maiorca, G. Brunori, R. Zubani, G.C. Cancarini, L. Manili, C. Camerini, E. Movilli, A. Pola, G. D'Avolio and U. Gelatti.- Brescia, Italy.

4:00 P.M. ---minisymposia--- San Diego Conv Ctr Rm 5ab
Adequacy of dialysis

Program number 626 at 5:00
* Comparison of mortality risk by Kt/V single pool versus doublepool analysis in diabetic and non-diabetic hemodialysis patients. N.W. Levin, D.C. Stannard, F. Gotch and F.K. Port. - Ann Arbor, MI.

Mon. Nov. 6 1995

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Complications and outcomes in end-stage renal disease I

Program number 852 Board# M121 at 10:00 A.M.
* Incidence of bacteremia in hemodialysis patients 1993-1994. B.A.J. Walters, M. Molina, A.F. Rosenthal, V. Didominic and S.J. Bander. - Nashville, TN.

Program number 888 Board# M157 at 10:00 A.M.
* Hypoalbuminemia: A major risk factor for cardiac disease in ESRD. R.N. Foley, P.S. Parfrey, J.D. Harnett, G.M. Kent, D.C. Murray and P.I. Barre. - St. John's and Montreal, Canada.

Program number 890 Board# M159 at 10:00 A.M.
* Effect of serial APACHE and organ failure scores on prediction of mortality in acute renal failure. R. Mehta, A. Farkas, M. Pascual and W. Fowler. - San Diego, CA.

Program number 892 Board# M161 at 10:00 A.M.
* Predictors of short-term mortality in diabetic hemodialysis patients. R.A. Ward, M.E. Brier, P. De Oreo, K.M. Erbeck, R.J. Hamburger and B.A.Smith. - Louisville, KY; Cleveland, OH and Indianapolis, IN.

Program number 896 Board# M165 at 10:00 A.M.
* Severe neuropathy predicts mortality in non-diabetic hemodialysis patients. N. Mittman, M.M. Avram, A. Castanares, K. Oo, J. Licht and R. Sreedhara. - Brooklyn, NY.

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Dialysis and outcome in acute renal failure

Program number 907 Board# M176 at 10:00 A.M.
* Acute comorbidities and mortality in patients with severe acute renal failure. G.M. Chertow, R.L. Allgren, J.M. Lazarus and M.H. Sayegh. - Boston, MA and Mountain View, CA.

Program number 908 Board# M177 at 10:00 A.M.
* Effect of delayed consultation on outcome from acute renal failure in the icu. R. Mehta, A. Farkas, M. Pascual and W. Fowler. - San Diego, Ca.

Program number 911 Board# M180 at 10:00 A.M.
* Clinical factors and outcome of established acute renal failure. F. Cantarovich and M. Verho. - Paris, France.

Program number 922 Board# M191 at 10:00 A.M.
* Impact of acute renal failure on mortality in end-stage liver disease with and without transplantation. D.S. Fraley, J. Bernardini, R. Burr, D. Angus, D. Kramer and J.P. Johnson. - Pittsburgh, PA.

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Nutrition and dialysis

Program number 996 Board# M265 at 10:00 A.M.
* High cytokine levels may mediate the high mortality of hemodialysis patients with low albumin and/or cholesterol. R.M. Bologa, D.M. Levine, T.S. Parker, D. Serur, K.H. Stenzel, A. Rubin and J.S. Cheigh. - New York, NY.

Program number 997 Board# M266 at 10:00 A.M.
* Mortality in dialysis patients with chemosensory disorders and malnutrition. J.H. Galla and H.J. Duncan. - Cincinnati, OH.

Tue. Nov. 7 1995

9:00 A.M. ---Poster--- San Diego Conv Ctr Halls A and B
Complications and outcomes in end-stage renal disease III

Program number 1595 Board# T145 at 10:00 A.M.
* Adequacy of dialysis and subsequent morbidity and mortality among adult U.S. Hemodialysis patients. J. Lowery, W. McClellan and S. Helgerson.- Atlanta, Ga and Seattle, WA.

Program number 1597 Board# T147 at 10:00 A.M.
* Early death in dialysis patients: Risk factors and impact on incidence and mortality rates. J.M. Soucie and W. McClellan. - Atlanta, GA and Raleigh, NC.

Program number 1601 Board# T151 at 10:00 A.M.
* Differences in causes of death of dialysis patients. L.U. Mailloux, B. Napolitano, A. Bellucci, M. Vernace, I. Miller, R.T. Mossey and B.Wilkes. - manhasset, NY.

Program number 1605 Board# T155 at 10:00 A.M.
* Patient mix and mortality in chronic hemodialysis. R.A. Wolfe, E. Mauger, P.J. Held, T. Golper, I. Sarsitis, J.D. Woods, L.Y.C. Agodoa and F.K. Port. - Ann Arbor, MI.

Program number 1610 Board# T160 at 10:00 A.M.
* A switch from conventional to high performance membrane can reduce a risk of carpal tunnel syndrome and mortality of hemodialysis patients. Y. Koda, S. Miyazaki, M. Suzuki, Y. Hirasawa and T. Nishi. - Niigata and Tokyo, Japan.

Program number 2103 at 4:00
* The relationship of dialysis membrane and cause-specific mortality in chronic hemodialysis patients. W.E. Bloembergen, F.K. Port, R.M. Hakim, D. Stannard, R.A. Wolfe, L.Y.C. Agodoa and P.J. Held. - Ann Arbor, MI.

Program number 2105 at 4:30
* Hypertension, Cardiomyopathy, Cardiac morbidity and mortality in ESRD. R.N. Foley, P.S. Parfrey, J.D. Harnett, G.M. Kent, D.C. Murray and P.E. Barre. - St. John's and Montreal, Canada.

Program number 2106 at 4:45
* Peritonitis influences mortality in PD patients. L. Fried, J. Bernardini, J.R. Johnston and B. Piraino. - Pittsburgh, PA.

Wed. Nov. 8 1995

10:00 A.M. ---Free Communications--- San Diego Conv Ctr Rm 5a
Dialysis adequacy: Applications and outcomes

Program number 2176 at 10:45
* Facility-specific standardized mortality ratio and Kt/V. R.A. Wolfe, P.J.Held, S.D. Helgerson, L.Y.C. Agodoa, C.A. Jones and F.K. Port. - Ann Arbor, MI.

10:00 A.M. ---Free Communications--- San Diego Conv Ctr Rm 8
Nutrition and metabolism in dialysis patients

Program number 2218 at 10:15
* Elevated serum C-reactive protein is a strong predictor of increased mortality and low serum albumin in hemodialysis patients. J. Bergstrom, O. Heimburger, B. Lindholm and A.R. Qureshi. - Huddinge and Stockholm, Sweden.

Use BACK arrow on your browser (faster) or click here to go back to ASN95 main page

UP Click on ARROW for HDCN Home Page.